Advertisement
Screener

Faeth Therapeutics, Inc. (FTH) ROA

Faeth Therapeutics, Inc. (FTH) ROA

  • 2026-06-30: ROA -103.29%.
  • 2026-03-31: ROA -89.81%.
  • 2025-12-31: ROA -92.07%.
  • 2025-09-30: ROA -87.50%.

Complete source-backed roa history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-103.29%
2026-03-31-89.81%
2025-12-31-92.07%
2025-09-30-87.50%
2025-06-30-84.39%
2025-03-31-75.85%
2024-12-31-66.48%
2024-09-30-55.96%
2024-06-30-49.62%
2024-03-31-47.85%
2023-12-31-45.85%
2023-09-30-47.66%
2023-06-30-50.47%
2023-03-31-42.95%
2022-12-31-41.05%
2022-09-30-35.50%
2022-06-30-30.42%
2022-03-31-27.48%
2021-12-31-24.01%
2021-09-30-20.19%
2021-06-30-16.84%
2021-03-31-13.40%
2020-12-31-93.80%

Annual ROA

DateROA
2025-12-31-92.07%
2024-12-31-66.48%
2023-12-31-45.85%
2022-12-31-41.05%
2021-12-31-24.01%
2020-12-31-93.80%

Similar stocks

Stock NameCountryMarket CapPE Ratio
COLLEGIUM PHARMACEUTICAL, INC (COLL)United States$0.737B24.57
Design Therapeutics, Inc. (DSGN)United States$0.766B-12.78
Wave Life Sciences, Inc. (WVE)$0.780B-5.56
Olema Pharmaceuticals, Inc. (OLMA)United States$0.790B-5.35
Aclaris Therapeutics, Inc. (ACRS)United States$0.792B-9.78
Verastem, Inc. (VSTM)United States$0.706B-1.71
Nuvectis Pharma, Inc. (NVCT)United States$0.705B-17.53
GERON CORP (GERN)United States$0.803B-12.14
IRONWOOD PHARMACEUTICALS INC (IRWD)United States$0.694B5.37
Climb Bio, Inc. (CLYM)United States$0.683B-13.03